- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Sai Life Sciences IPO
₹764.65
+39.28% on listing
Listing-day close · NSE · 18 Dec 2024 · issue price ₹549
Sai Life Sciences’ ₹3,043 crore IPO was priced at ₹549 a share. It listed on the NSE on 18 Dec 2024 and closed its first day at ₹764.65, up 39.28% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹3,043 Cr
- Fresh issue
- ₹950 Cr
- Offer for sale
- ₹2,093 Cr
- Lot size
- 27 shares
- Minimum investment
- ₹14,823
- Face value
- ₹1
- Registrar
- Kfin Technologies
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 7.50× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹11,419 Cr
- P/E (post-issue)
- 203.8
- EPS (post-issue)
- ₹2.69
- Price to book
- 10.2
- ROE
- 11.79%
- ROCE
- 15.96%
- PAT margin
- 5.65%
- Promoter holding
- 41.82% → 35.24%
Financials as of 31 Mar 2024, from the offer documents.
Listing
- Listing date
- 18 Dec 2024
- Issue price
- ₹549
- Open
- ₹650.00
- High
- ₹780.00
- Low
- ₹650.00
- Close
- ₹764.65
Listing day on the NSE. The close was +39.28% on the issue price.
SAI LIFE SCIENCES share price todayFAQs
When did the Sai Life Sciences IPO open and close?
It opened on 11 Dec 2024 and closed on 13 Dec 2024.
What was the Sai Life Sciences IPO price?
The price band was ₹522–549 a share. The final issue price was ₹549.
What is the lot size and minimum investment?
One lot is 27 shares, ₹14,823 at ₹549 a share. Retail investors apply in whole lots.
How much did Sai Life Sciences raise?
₹3,043 crore: ₹950 crore of new shares and ₹2,093 crore offered by existing shareholders.
How many times was the Sai Life Sciences IPO subscribed?
7.50 times overall.
How did Sai Life Sciences list?
It listed on the NSE on 18 Dec 2024 at ₹650.00 and closed the day at ₹764.65, up 39.28% on the ₹549 issue price.
Who is the registrar of the Sai Life Sciences IPO?
Kfin Technologies handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app